Best Options Strategy for KYMR
Looking for the best options strategy for Kymera Therapeutics, Inc. (KYMR)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live KYMR option chain right now, and a simple map from your view on KYMR to the strategy that fits it. Model any of them in the calculator before you trade.
About Kymera Therapeutics, Inc.
Kymera Therapeutics is a clinical-stage biopharmaceutical company developing small molecule drugs designed to eliminate disease-causing proteins by exploiting the body's natural protein disposal mechanisms. The company's lead candidate, KT-621, is an oral STAT6 degrader currently in Phase 2b testing for inflammatory and allergic conditions including atopic dermatitis, asthma, COPD, and eosinophilic esophagitis. Its pipeline also includes KT-579, an IRF5 degrader in Phase 1 trials targeting autoimmune diseases like lupus and rheumatoid arthritis, and KT-485, an IRAK4 program in Phase 2 development for conditions such as hidradenitis suppurativa and atopic dermatitis. The company is also exploring a CDK2 program with potential applications across various solid tumors and breast cancer.
Kymera generates revenue primarily through its partnership with Sanofi, which has licensed rights to develop IRAK4-targeting candidates for non-oncology and non-immuno-oncology indications. As a clinical-stage company, it remains pre-commercial and relies on this collaboration, equity financing, and milestone payments to fund operations. Founded in 2015 and based in Watertown, Massachusetts, Kymera…
Today's top-scoring strategy for KYMR
Our engine ranks defined-risk strategies on the live KYMR chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | PUT | $85 | $1.43 |
| Sell | 1× | PUT | $100 | $2.75 |
| Sell | 1× | CALL | $120 | $4.33 |
| Buy | 1× | CALL | $135 | $2.48 |
Simulazione
Simulazione prospettica di 6,000 traiettorie di prezzo lognormali fino alla scadenza — non è un backtest storico.
Analisi della strategia
Greche vs prezzo
Prezzo × volatilità (oggi)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $139 | −$783 | −$724 | −$686 | −$666 | −$660 |
| $133 | −$609 | −$579 | −$567 | −$570 | −$583 |
| $128 | −$413 | −$425 | −$448 | −$478 | −$512 |
| $122 | −$222 | −$280 | −$340 | −$398 | −$453 |
| $116 | −$69 | −$169 | −$260 | −$341 | −$412 |
| $111 | $7 | −$116 | −$224 | −$318 | −$398 |
| $105 | −$19 | −$139 | −$246 | −$338 | −$416 |
| $100 | −$156 | −$246 | −$329 | −$404 | −$470 |
| $94 | −$384 | −$424 | −$467 | −$512 | −$555 |
| $89 | −$652 | −$639 | −$639 | −$650 | −$667 |
| $83 | −$896 | −$849 | −$817 | −$799 | −$791 |
Live scan from 2026-07-22 · quotes delayed ~15 minutes
Backtest storico: come si sarebbe comportata una Iron Condor su KYMR
Abbiamo simulato in modo approssimativo una Iron Condor su KYMR che avresti aperto ripetutamente nell'ultimo anno (93 ingressi storici, ciascuno mantenuto fino alla scadenza), con i premi d'ingresso modellati tramite Black-Scholes. Ecco come sarebbe andata sulla reale storia dei prezzi di KYMR — un backtest didattico, non una previsione dei rendimenti futuri.
In via approssimativa: i premi d'ingresso sono modellati con Black-Scholes sulla base della volatilità realizzata trailing, mantenuti fino alla scadenza e regolati contro il reale prezzo di chiusura storico. Fill reali, volatilità implicita e slippage differiscono — consideralo come contesto indicativo, non come rendimento esatto.
Implied volatility
KYMR is currently trading with high implied volatility, which makes its options expensive — and attractive to sell. On the options we scanned that was around 60% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on KYMR currently price in about 60% implied volatility, versus roughly 71% the stock has actually realised over the past month. The two are roughly in line, so neither buying nor selling premium has a clear volatility edge here.
Off that volatility, the options market is pricing a move of about ±$18,95 (±17%) in KYMR by 2026-08-21 — a range of roughly $91,95 to $130. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, puts and calls on KYMR carry a fairly symmetric implied volatility — no strong directional fear is priced in either way.
In evidenza dalla option chain di KYMR: open interest, volume e skew
La option chain live di KYMR mostra un rapporto put/call sull'open interest di 1.16 (balanced), con una volatilità implicita at-the-money intorno al 62.7%. L'open interest si concentra sulla call a 130 — un classico "muro" di resistenza — e sulla put a 80, un "muro" di supporto: esattamente gli strike a cui gli scrittori di opzioni sono più esposti verso la scadenza.
Istantanea di open interest, volume e volatilità implicita per la scadenza scansionata più vicina — contesto, non un segnale di trading.
Insider trading su KYMR (SEC Form 4)
Operazioni degli insider sul mercato aperto relative a KYMR negli ultimi sei mesi circa, tratte dalle comunicazioni SEC Form 4. Gli acquisti sul mercato aperto sono il segnale più raro e più forte — le vendite di routine effettuate nell'ambito di piani prestabiliti sono frequenti, quindi leggi un dato di vendita netta tenendolo presente.
| Insider | Azione | Azioni | Valore | Data |
|---|---|---|---|---|
| Mainolfi Nello | Vendita | 50.000 | $6.0M | 2026-07-07 |
| Goodman Noah | Vendita | 3389 | $387K | 2026-07-01 |
| Mainolfi Nello | Vendita | 3336 | $389K | 2026-07-01 |
| Mainolfi Nello | Vendita | 44.050 | $5.1M | 2026-07-01 |
| Mainolfi Nello | Vendita | 24.105 | $2.8M | 2026-07-01 |
| Mainolfi Nello | Vendita | 6626 | $755K | 2026-07-01 |
Fonte: comunicazioni SEC Form 4 tramite Finnhub. Solo acquisti (P) e vendite (S) sul mercato aperto — assegnazioni, esercizi di opzioni, donazioni e ritenute fiscali sono esclusi. Contesto informativo, non consulenza sugli investimenti.
Liquidity and tradeability
KYMR options are thinly traded, with wide bid-ask spreads around 39,2% near the money that eat into any edge — favour simple single-leg or tight defined-risk trades, and always use limit orders.
Key figures
- Market cap
- $9.1B
- Beta (vs market)
- 1.96
- 52-week range
- $36.65–$130.05 (79% up the range)
- Short interest
- 15.9% of float · 8.0 days to cover
With 15.9% of KYMR's float sold short, squeeze and gap risk are elevated — one reason its options can stay expensive.
How to choose an options strategy for KYMR
Start with your outlook on KYMR, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while KYMR stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open KYMR in the free calculator →
Domande frequenti
What is the best options strategy for KYMR?
It depends on your outlook. Bullish traders often use a long call or bull call spread on KYMR; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are KYMR options liquid enough to trade?
Kymera Therapeutics, Inc. (KYMR) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade KYMR options?
Buying a single KYMR call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade KYMR or any security. Do your own research.
Cosa fa Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. (KYMR) opera nel settore Biotechnology. La sezione "Informazioni su Kymera Therapeutics, Inc." qui sopra offre un quadro più completo di ciò che fa l'azienda e di come genera profitti.
Kymera Therapeutics, Inc. paga dividendi?
Qui non mostriamo un rendimento da dividendo confermato per Kymera Therapeutics, Inc., quindi consideralo incerto: prima di scrivere delle call controlla il dividendo attuale e la data di stacco cedola (ex-dividend) presso il tuo broker — una data di stacco imminente può innescare un'assegnazione anticipata sulle call scritte in-the-money.
Tickers related to KYMR
Comparing KYMR with similar names can help you choose the best options strategy:
Informazioni sull’azienda
- Sede
- 500 North Beacon Street, 4th Floor, Watertown, MA, 02472, United States
- Settore
- Biotechnology
- Dipendenti
- 253
- CEO
- Dr. Nello Mainolfi M.D., Ph.D.
- Telefono
- 857 285 5300
- Sito web
- www.kymeratx.com
Best Options Strategy by Ticker →
Solo per uso didattico. Le quotazioni sono ritardate di circa 15 minuti e nulla di ciò che è riportato qui è consulenza finanziaria. Il trading di opzioni comporta un rischio sostanziale di perdita. Privacy · Terms.